These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9200454

  • 1. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
    Kitanaka A, Ito C, Coustan-Smith E, Campana D.
    J Immunol; 1997 Jul 01; 159(1):184-92. PubMed ID: 9200454
    [Abstract] [Full Text] [Related]

  • 2. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain.
    Kitanaka A, Suzuki T, Ito C, Nishigaki H, Coustan-Smith E, Tanaka T, Kubota Y, Campana D.
    J Immunol; 1999 Feb 15; 162(4):1952-8. PubMed ID: 9973464
    [Abstract] [Full Text] [Related]

  • 3. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.
    Silvennoinen O, Nishigaki H, Kitanaka A, Kumagai M, Ito C, Malavasi F, Lin Q, Conley ME, Campana D.
    J Immunol; 1996 Jan 01; 156(1):100-7. PubMed ID: 8598449
    [Abstract] [Full Text] [Related]

  • 4. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.
    Kitanaka A, Ito C, Nishigaki H, Campana D.
    Blood; 1996 Jul 15; 88(2):590-8. PubMed ID: 8695807
    [Abstract] [Full Text] [Related]

  • 5. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
    Inoue S, Kontani K, Tsujimoto N, Kanda Y, Hosoda N, Hoshino S, Hazeki O, Katada T.
    J Immunol; 1997 Dec 01; 159(11):5226-32. PubMed ID: 9548461
    [Abstract] [Full Text] [Related]

  • 6. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
    Lund FE, Yu N, Kim KM, Reth M, Howard MC.
    J Immunol; 1996 Aug 15; 157(4):1455-67. PubMed ID: 8759726
    [Abstract] [Full Text] [Related]

  • 7. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
    Li X, Sandoval D, Freeberg L, Carter RH.
    J Immunol; 1997 Jun 15; 158(12):5649-57. PubMed ID: 9190913
    [Abstract] [Full Text] [Related]

  • 8. The signaling activity of murine CD19 is regulated during cell development.
    Krop I, Shaffer AL, Fearon DT, Schlissel MS.
    J Immunol; 1996 Jul 01; 157(1):48-56. PubMed ID: 8683154
    [Abstract] [Full Text] [Related]

  • 9. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y, Rodriguez R, Bjorndahl J, Phillips CA, Trevillyan JM.
    Eur J Immunol; 1996 Jun 01; 26(6):1278-84. PubMed ID: 8647205
    [Abstract] [Full Text] [Related]

  • 10. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
    Lund FE, Solvason NW, Cooke MP, Health AW, Grimaldi JC, Parkhouse RM, Goodnow CC, Howard MC.
    Eur J Immunol; 1995 May 01; 25(5):1338-45. PubMed ID: 7774637
    [Abstract] [Full Text] [Related]

  • 11. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L, An S, Gunby RH, Kelly K, Radda GK, Knox KA.
    Cell Immunol; 1997 May 01; 177(2):119-28. PubMed ID: 9178638
    [Abstract] [Full Text] [Related]

  • 12. Association of phosphatidylinositol 3-kinase with the proto-oncogene product Cbl upon CD38 ligation by a specific monoclonal antibody in THP-1 cells.
    Matsuo T, Hazeki K, Tsujimoto N, Inoue S, Kurosu H, Kontani K, Hazeki O, Ui M, Katada T.
    FEBS Lett; 1996 Nov 11; 397(1):113-6. PubMed ID: 8941725
    [Abstract] [Full Text] [Related]

  • 13. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S, Barel M, Frade R.
    J Immunol; 1999 Jan 01; 162(1):136-43. PubMed ID: 9886379
    [Abstract] [Full Text] [Related]

  • 14. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages.
    Funaro A, De Monte LB, Dianzani U, Forni M, Malavasi F.
    Eur J Immunol; 1993 Oct 01; 23(10):2407-11. PubMed ID: 8405040
    [Abstract] [Full Text] [Related]

  • 15. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
    Ishiura N, Nakashima H, Watanabe R, Kuwano Y, Adachi T, Takahashi Y, Tsubata T, Okochi H, Tamaki K, Tedder TF, Fujimoto M.
    Eur J Immunol; 2010 Apr 01; 40(4):1192-204. PubMed ID: 20101619
    [Abstract] [Full Text] [Related]

  • 16. CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.
    Roifman CM, Ke S.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):222-5. PubMed ID: 7687428
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of interleukin 4-induced down-regulation of CD38 on human B cells.
    Shubinsky G, Schlesinger M.
    Cell Immunol; 1996 Oct 10; 173(1):87-95. PubMed ID: 8871604
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 19. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF.
    J Immunol; 1999 Jun 15; 162(12):7088-94. PubMed ID: 10358152
    [Abstract] [Full Text] [Related]

  • 20. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
    Weng WK, Shah N, O'Brien D, Van Ness B, LeBien TW.
    J Immunol; 1997 Dec 01; 159(11):5502-8. PubMed ID: 9548490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.